Filter News
Area of Research
- (-) Biology and Environment (10)
- (-) Quantum information Science (9)
- Advanced Manufacturing (2)
- Clean Energy (18)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (9)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (1)
- Materials (24)
- Materials for Computing (3)
- National Security (27)
- Neutron Science (14)
- Nuclear Science and Technology (1)
- Supercomputing (66)
News Topics
- (-) Artificial Intelligence (9)
- (-) Cybersecurity (3)
- (-) Quantum Science (9)
- 3-D Printing/Advanced Manufacturing (11)
- Advanced Reactors (1)
- Big Data (9)
- Bioenergy (46)
- Biology (73)
- Biomedical (16)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (11)
- Clean Water (11)
- Climate Change (40)
- Composites (5)
- Computer Science (25)
- Coronavirus (13)
- Critical Materials (1)
- Decarbonization (19)
- Energy Storage (7)
- Environment (89)
- Exascale Computing (4)
- Frontier (3)
- Fusion (1)
- Grid (4)
- High-Performance Computing (20)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (8)
- Materials (12)
- Materials Science (6)
- Mathematics (3)
- Mercury (7)
- Microscopy (12)
- Molten Salt (1)
- Nanotechnology (8)
- National Security (3)
- Net Zero (2)
- Neutron Science (4)
- Nuclear Energy (1)
- Partnerships (5)
- Physics (3)
- Polymers (2)
- Renewable Energy (1)
- Security (2)
- Simulation (14)
- Summit (10)
- Sustainable Energy (31)
- Transformational Challenge Reactor (1)
- Transportation (3)
Media Contacts
Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.
Wildfires have shaped the environment for millennia, but they are increasing in frequency, range and intensity in response to a hotter climate. The phenomenon is being incorporated into high-resolution simulations of the Earth’s climate by scientists at the Department of Energy’s Oak Ridge National Laboratory, with a mission to better understand and predict environmental change.
Nature-based solutions are an effective tool to combat climate change triggered by rising carbon emissions, whether it’s by clearing the skies with bio-based aviation fuels or boosting natural carbon sinks.
ORNL researchers discovered genetic mutations that underlie autism using a new approach that could lead to better diagnostics and drug therapies.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory and the Georgia Institute of Technology is using supercomputing and revolutionary deep learning tools to predict the structures and roles of thousands of proteins with unknown functions.
Of the $61 million recently announced by the U.S. Department of Energy for quantum information science studies, $17.5 million will fund research at DOE’s Oak Ridge National Laboratory. These projects will help build the foundation for the quantum internet, advance quantum entanglement capabilities — which involve sharing information through paired particles of light called photons — and develop next-generation quantum sensors.
To minimize potential damage from underground oil and gas leaks, Oak Ridge National Laboratory is co-developing a quantum sensing system to detect pipeline leaks more quickly.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.